Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 1;136(9):1025-1031.
doi: 10.1001/jamaophthalmol.2018.2664.

Development and Evaluation of Diagnostic Criteria for Vogt-Koyanagi-Harada Disease

Peizeng Yang  1 , Yuanyuan Zhong  1 , Liping Du  1 , Wei Chi  2 , Ling Chen  3 , Rui Zhang  3 , Meifen Zhang  4 , Hong Wang  5 , Hong Lu  6 , Liu Yang  7 , Wenjuan Zhuang  8 , Yan Yang  9 , Lin Xing  10 , Lei Feng  11 , Zhengxuan Jiang  12 , Xiaomin Zhang  13 , Yuqin Wang  14 , Hui Zhong  15 , Liqiong Jiang  16 , Changlin Zhao  17 , Fuzhen Li  18 , Shuang Cao  19 , Xiaoli Liu  20 , Xuan Chen  21 , Yanyun Shi  22 , Weizhong Zhao  23 , Aize Kijlstra  24
Affiliations

Development and Evaluation of Diagnostic Criteria for Vogt-Koyanagi-Harada Disease

Peizeng Yang et al. JAMA Ophthalmol. .

Abstract

Importance: To our knowledge, a set of well-defined diagnostic criteria is not yet developed for the diagnosis of Vogt-Koyanagi-Harada (VKH) disease.

Objective: To develop and evaluate a set of diagnostic criteria for VKH disease using data from Chinese patients.

Design, setting, and participants: This case-control study reviewed medical records of patients from a tertiary referral center between October 2011 and October 2016. Data from 634 patients with VKH disease and 623 patients with non-VKH uveitis from southern China were used to develop the Diagnostic Criteria for VKH Disease (DCV). Data from an additional group of 537 patients with a definite VKH disease diagnosis and 525 patients with non-VKH uveitis from northern China were used to evaluate the diagnostic criteria.

Main outcomes and measures: Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and receiver operating characteristic.

Results: Of the 1257 patients used to construct the DCV, 665 (52.9%) were male, and the mean (SD) age at disease onset was 38.6 (13.6) years. The 3-class model and 21 clinical findings were selected by latent class analysis. Variables with a high positive rate in the early-phase or late-phase VKH group or high specificity constituted essential parameters. Constellations of these essential parameters constructed the DCV. The sensitivity and NPV of the DCV were higher than those of the Revised Diagnostic Criteria for VKH Disease (RDC) (sensitivity: 94.6% vs 71.9%; difference, 22.7%; 95% CI, 18.5-27.0; NPV: 94.3% vs 76.6%; difference, 17.7%; 95% CI, 13.9-21.5). The specificity and PPV of the DCV were not different from that of the RDC (specificity: 92.2% vs 93.9%; difference, 1.7%; 95% CI, -1.4 to 4.8; PPV: 89.3% vs 92.3%; difference, 3.0%; 95% CI, -1.4 to 4.8). The area under the receiver operating characteristic curve of the DCV and the RDC were 0.934 (95% CI, 0.917-0.951) and 0.829 (95% CI, 0.803-0.855), respectively.

Conclusions and relevance: The DCV were developed and evaluated using data from Chinese patients with VKH disease and showed a high sensitivity, NPV, and area under the receiver operating characteristic curve in comparison with the RDC. However, they were developed using a retrospective analysis and should be evaluated in prospective studies in other racial/ethnic populations.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.

Figures

Figure.
Figure.. Receiver Operating Characteristic Curves of the Diagnostic Criteria for Vogt-Koyanagi-Harada Disease (DCV) and the Revised Diagnostic Criteria for Vogt-Koyanagi-Harada Disease (RDC)
See this image and copyright information in PMC

Comment in

References

    1. Snyder DA, Tessler HH. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1980;90(1):69-75. doi:10.1016/S0002-9394(14)75078-0 - DOI - PubMed
    1. Sugiura S. Some observations on uveitis in Japan, with special reference to Vogt-Koyanagi-Harada and Behçet diseases (author’s transl) [in Japanese]. Nippon Ganka Gakkai Zasshi. 1976;80(11):1285-1326. - PubMed
    1. Sugiura S. Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 1978;22:9-35. - PubMed
    1. Read RW, Holland GN, Rao NA, et al. . Revised Diagnostic Criteria for Vogt-Koyanagi-Harada Disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131(5):647-652. doi:10.1016/S0002-9394(01)00925-4 - DOI - PubMed
    1. da Silva FT, Damico FM, Marin ML, et al. . Revised Diagnostic Criteria for Vogt-Koyanagi-Harada Disease: considerations on the different disease categories. Am J Ophthalmol. 2009;147(2):339-345.e5. doi:10.1016/j.ajo.2008.08.034 - DOI - PubMed

Publication types